Ipamorelin
Growth Hormone Secretagogue
Ipamorelin is a synthetic pentapeptide growth hormone secretagogue (GHS) that selectively activates the ghrelin/GHS receptor. Unlike other GHS compounds, Ipamorelin does not significantly affect cortisol or prolactin levels in research models.
- GHS-R1a Selectivity
- GH Release
- Minimal Cortisol Effect
- Pulsatile Secretion
Quantified findings reported in the literature
Published, peer-reviewed studies
Ipamorelin, the first selective growth hormone secretagogue
Characterization of Ipamorelin as the first GHS with selectivity for GH release without significant effects on ACTH, cortisol, or prolactin levels.
View source on PubMed/DOI ↗Growth hormone releasing peptides and the regulation of GH secretion
View source on PubMed/DOI ↗
Third-party analytical reports
Certificates of Analysis from independent laboratories for products supplied by Stemcode. Reported values describe the analysed material; they are reported as documented and are distinct from the published literature above.
- Net content
- 1.94 mg/mL
- Lot
- IPN20mg-2501
- COA #
- 2603200345
- Report date
- 03/23/2026
- Net content
- 1.78 mg/mL
- Lot
- IPN20MG-2501
- COA #
- #86877
- Report date
- 11/10/2025
Stemcode supplies Ipamorelin as a research-grade compound for laboratory research use only — not for human or animal consumption.
View the research-grade product →